反応式
O[CH:2]1[O:6][C:5](=O)[CH:4]=[C:3]1[CH3:8].Cl.[NH:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[NH2:11]>C(O)C>[CH3:2][C:3]1[CH:8]=[N:11][N:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[C:5](=[O:6])[CH:4]=1参加物
4
実験手順
5-Hydroxy-4-methylfuran-2(5H)-one (1.19 g, 10.4 mmol) and ethyl hydrazinoacetate hydrochloride (1.61 g, 10.4 mmol) in 95% ethanol (20 mL) was refluxed for 2 h. Removal of the solvent in vacuo followed by purification using a Biotage Horizon® system (0-50% ethyl acetate/hexanes mixture) gave ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate as a yellow crystalline. LC/MS 219.2 (M+23).
後処理
- customRemoval of the solvent in vacuo
- customfollowed by purification
出典と根拠
- ORDレコード
- ord-3219945a94c34963a373004fac3c590c
- 出典データセット
- uspto-grants-2014_02
- 特許番号
- US08653260B2
関連ノート
読み込み中…